Ms. Stafford has served as our Chief Financial Officer since April 2026. She recently served as Senior Vice President, Chief Accounting Officer for Royalty Pharma plc, from December 2018 to March 2026. Prior to this position, Ms. Stafford served as Vice President, Finance of Royalty Pharma and Chief Financial Officer of BioPharma Credit plc, an affiliate of Royal Pharma, from 2016 to 2018. Previously, she was a director at Ernst & Young LLP Capital Markets in London, specializing in U.S. transactions involving European life sciences companies. She also previously managed the external SEC reporting for iHeartMedia and was an auditor at Deloitte. Ms. Stafford is currently a Board Member at Novocure. She is a CPA and holds a B.Sc. degree in business administration from Sonoma State University